Malaria is caused by a single-celled organism of the Plasmodium family, a parasite, carried by the infected female Anopheles mosquitoes, which enters the body destroying the RBC’s, leading to symptoms like chills, fever, headaches, muscle aches, fatigue, nausea, vomiting, diarrhoea and in some serious cases jaundice and anaemia.
Treatment of malaria depends on many factors including the severity of the disease, the species of malaria parasite, the part of the world the infection was acquired and whether or not any preventative antimalarial tablets were taken prior to visiting.
Antimalarial drugs are often used in combination with each other to make sure the malaria parasite is removed from all areas of the body. Such combination therapies are termed as artemisinin combination therapy (ACT), which uses an artemisinin-based drug plus one partner drug to treat Plasmodium falciparum malaria.
Frequently prescribed preventative Antimalarials include Doxycycline, Chloroquine and a combination of Atovaquone and Proguanil.
However, some Antimalarial drugs can only be used in certain areas of the world because parasites are resistant to some drugs. For instance, according to research conducted, Chloroquine can only be used to prevent Plasmodium falciparum in regions of South America because Plasmodium falciparum is completely resistant to Chloroquine in Africa and Asia.
Following is the list of Antimalarial drugs catered to manufacturers worldwide by Aravis Pharmaceuticals.
|Quinine Sulphate Tablets
|alpha- ß Arteether Injection
|Chloroquine phosphate Injection
|20mg/m | 40mg/ml | 60mg/ml | 80mg/ml
|Quinine Dhydrochloride Injection
|250mg/ml | 500mg/ml